## Note
nid: 1509302289236
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Lolnotacop::Drugs, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Alemtuzumab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::20_Alemtuzumab, #AK_Step1_v11::#OME_banner::Basic_Science::07_Immunology, #AK_Step1_v11::#Physeo::09_Pharm::17_Hem/Onc_Pharm::Rituximab_Bevacizumab_Alemtuzumab_Cetuximab_Panitumumab_Trastuzmab, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Rituximab,_cetuximab,_bevacizumab,_alemtuzumab,_trastuzumab
markdown: false

### Text
<b>Alemtuzumab</b> is an <u>antitumor</u> monoclonal antibody that
targets <b>{{c1::CD52</b><b>}}</b> of lymphocytes

### Extra
<div>
  results in a direct cytotoxic effect (antibody-dependent
  cell-mediated)
</div><img src="paste-28544352649707.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-34286723923971.jpg"><img src=
"paste-34359738368003.jpg"><img src=
"paste-34398393073667.jpg"><img src="paste-34540126994435.jpg">

### Sketchy
<img src="paste-390537081257985.jpg"><img src=
"paste-87d74ac95a67d78e1a0443bd770c17f44240fcf8.png"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-antineoplastics/videos/medical-pharmacology-antineoplastics-kinase-inhibitors-and-monoclonal-antibodies-rituximab-cetuximab-bevacizumab-alemtuzumab-trastuzumab?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Rituximab, cetuximab, bevacizumab, alemtuzumab,
trastuzumab</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/immunology?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_2.png"></a>
</div>

### Additional Resources


### One by one

